Articles

Recommended paracetamol doses and labelling rquirements

Direction Notice issued to cease advertising of therapeutic goods not entered in the ARTG

Direction Notice issued to cease advertising of unregistered therapeutic goods to consumers

The TGA will not pursue the development of an alternative quality standard for sunscreen excipient ingredients at this time in 2019.

Safety information: regulators review balloon and stent devices used to unblock blood vessels in the legs

An individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China

Infringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products

Information for consumers on the use of performance and image enhancing drugs

Information on how supplements are regulated in Australia

Changes will be made to the regulation of nappy rash products on 1 January 2020

Improvements to Consumer Medicine Information

Important information about the dangers of using thermography for breast cancer detection

If you have any unwanted medicines, you can safely dispose of them at your local pharmacy.

The Federal Court has imposed substantial penalties on Peptide Clinics Australia

Risks associated with cosmetic injections can be related to both the product and the experience of the person performing the procedure

The TGA has clarified that state and territory governments will continue to regulate fluoridated drinking water in Australia

Medicines Safety Update article

The TGA is urging Australians to return unused prescription pain relief medicines to their local pharmacy

Tips on what to consider when choosing or applying a sunscreen

New regulations for stem cell treatments in Australia came into force on 1 July 2019

The 2019 TGA stakeholder survey is open. Have your say before 5 July

We're encouraging all Australians to return their unused opioids to their local pharmacy

International work-sharing initiative approves Niraparib (Zejula®)

The transition period for updating medicine ingredient names ends on 30 April 2020.

Bee aware of the risks of natural medicines and medical devices.